Delivery Order SPE2DB25D9320-SPE2DB25FWFCD
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on August 8, 2025. The contract, with an ultimate completion date of August 11, 2025, provides for the delivery of Jakafi 10 mg tablets (60-count units) under a firm fixed-price arrangement. This delivery order was issued without a set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $10,937.15 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for 60 tablets of Jakafi 15 mg to support medical treatment facilities operated by the Defense Logistics Agency. DMS Pharmaceutical Group will provide the pharmaceutical products from their location in Park Ridge, Illinois, with delivery required by December 12, 2023. As a woman-owned small business, DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65,476.32 for Jakafi 10 mg tablets (60-count units) by the Defense Logistics Agency on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's substantial pharmaceutical supply relationship with the Department of Defense....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Jakafi 10 mg tablets, a specialty pharmaceutical product, with a performance period through January 14, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand twenty dollars and forty-nine cents ($11,020.49) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide sixty tablets of Jakafi, a medication used to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, valued at $12,115.65, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois...
- The U.S. government awarded a delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the provision of the pharmaceutical product Jakafi 10 mg tablet. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFCDDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 7, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025, with performance to be executed in Park Ridge, Illinois. The award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. This delivery order falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Through this overarching contract vehicle, the Defense Logistics Agency maintains the flexibility to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities. DMS Pharmaceutical Group's consistent success in securing such awards demonstrates its competitive strength in federal procurement markets and underscores the company's significance as a pharmaceutical distributor for military health systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/7/25 |